CHOP’s Center for Fetal Diagnosis and Treatment and Fetal Heart Program, performs fourth successful fetal heart surgery to remove life-threatening tumor.

Two research teams in CHOP’s Cardiac Center have been awarded research grants to study single ventricle congenital heart disease.

The conference is held under the patronage of H.E. Sheikh Nahyan bin Mubarak Al Nahyan and in collaboration with the Department of Health – Abu Dhabi (DOH).

Inaugural International Middle East Fetal-Neonatal Cardiovascular Symposium will be held in Abu Dhabi.

A year after the signing of the Abraham Accords — a declaration recognizing the importance of strengthening peace around the world — leaders and clinicians from CHOP hosted a meeting to share knowledge and research with pediatric experts from CHOP, the U.A.E. and Israel.

CHOP researchers found that children with Fontan circulation are slightly shorter than their peers, but further studies are needed to determine whether this effect is long-lasting.

In the middle of the COVID-19 pandemic, one Virginia family chose CHOP for their daughter’s heart repair.

The Fetal Heart Program at CHOP is one of the first programs in the world to begin incorporating provocative testing with maternal hyperoxygenation in our fetal echocardiography imaging suite.

The Fetal Heart Program provides comprehensive, compassionate care that addresses the medical as well as psychosocial effects of a family’s experience in the setting of a fetal congenital heart disease diagnosis.

Data collected by CHOP's new Birth Defects Biorepository will be used to investigate factors that may cause birth defects and that may modify the long-term outcomes.